SG health tech startup MiyaHealth pockets additional funding to expand global reach

Singapore-based healthtech startup MiyaHealth has announced raising additional funds in its pre-Series A round anchored by healthcare and technology investors including HealthXCapital, Central Capital Ventura, and SEEDS Capital.

This comes after MiyaHealth raised $6.5 million pre-Series A in February this year, which was one of the largest pre-Series A rounds by a healthtech start-up in Southeast Asia. MiyaHealth said it will use the fresh funds to accelerate the company’s product development, hiring, and expansion plans.

The pre-Series A round earlier this year was led by ST Engineering Ventures, the corporate capital arm of Singapore Technologies Engineering (ST Engineering) and Elev8, a deep-tech B2B focused VC fund based in Singapore.

Together with HealthXCapital, Central Capital Ventura, and SEEDS Capital, the funds will drive MiyaHealth’s aggressive growth strategy across the globe, starting with Europe and Southeast Asia.

“Following our successful pre-Series A fundraise, we are delighted to onboard new investors to further scale our product capabilities and expand our operations globally, starting with Europe and Southeast Asia,” said Dr Ramesh Rajentheran, Chief Executive Officer & Co-Founder of MiyaHealth.

With an aim to build technology that elevates every part of the patient journey, MiyaHealth has partnered with over 3,000 medical providers and 12,000 physicians to date for its flagship platforms, including its partnership with a leading hospital group in Indonesia.

Following inbound investor interest, MiyaHealth is also planning to kick-off its Series A fundraise in the next six months to further develop its product suite, expand its operations globally and continue embarking on collaborations with key stakeholders moving forward.

With a mission to improve patients’ healthcare journey, and to better serve the needs of payors and healthcare providers, MiyaHealth has launched a suite of products since its inception in 2019.

This includes MiyaPatient, a patient navigation platform with a predictive and personalized system that helps patients with chronic diseases cope with daily challenges; MiyaPayor, a platform that incorporates AI-driven claims processing, provider network management and predictive analytics to reduce costs for payors; and MiyaProvider, an upcoming product that improves patients’ experience in hospitals and clinics.